RxDoctor Payments Data

David Schroder, MD

Orthopaedic Surgery · Towson, MDNPI 1710935853

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,694 of the $39,378 with a category attached, or 72.9%. Globus Medical accounts for 86.7% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $13,530 and has fallen 93.3% since, to $911 in 2025.

$39,378in general payments, 2019–2025

Across 87 payments — averaging $452.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$34K
  • Smith+Nephew$2K
  • Stryker$1K
  • Johnson & Johnson$955
  • Zimmer Biomet$380
  • Anika Therapeutics, Inc.$348
  • plus $682 from 7 others

What the payments were for

  • Royalty or licence$560%
  • Consulting fees$28,69473%
  • Speaking & faculty fees$1,5754%
  • Travel & lodging$5,65314%
  • Food & beverage$3,4009%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,378 in reported general payments places this provider in the 85th percentile of 378 orthopaedic surgery providers in Maryland.

See all orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$562,973
Medicare patients
813
Services billed
4,209

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin170$1,316
Meloxicam254$888
Gabapentin62$251
Diclofenac Sodium16$194
Amoxicillin76$146
Methylprednisolone18$138
Doxycycline Hyclate15$129
Celecoxib11$80
Clindamycin Hcl11$43

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Towson

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →